The total worth of the marijuana market will reach US$166 billion by 2025, according to a market report made public on Tuesday (February 26) from Euromonitor International.

The firm expects legal cannabis to represent over 70 percent of the total market globally by the target date.


Zora Milenkovic, head of drinks and tobacco at Euromonitor International, said cannabis will serve as an ingredient in several consumer goods.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The researcher highlighted food, beverages, beauty, health and tobacco as the ones with highest potential of disruption from the growing cannabis market.

At the same time, the industry will continue to experience exponential growth while alcohol and tobacco will grow at a much slower pace, the report says.

“From 2018 to 2025, legal cannabis is estimated to grow more than 2,000 percent globally, compared to alcoholic drinks at 1.4 percent and tobacco at 1.2 percent,” the research firm indicated.

As the cannabis legalization movement continues across the globe, Canadian marijuana firms with first mover status in the industry have moved forward with expansion plans internationally.

Through joint ventures, acquisitions and other business tactics, Canadian cannabis companies pursue ventures across the legal marijuana map.

“Euromonitor International expects global sales of packaged food with CBD to double over the next two years, further blurring the lines between consumer health and food,” the research firm wrote.

Cannabidiol (CBD) has picked up in consumer interest as the product, derived from hemp, finds its way to the US market.

Cannabis companies across the US and Canada have started pursuing operations involving hemp production to enter the CBD market.

Projections for global market value continue rising

In January, financial institution Cowen’s (NASDAQ:COWN) raised its outlook on the overall value of the cannabis industry.

Vivien Azer, managing director and senior research analyst specializing in the beverage, tobacco, and cannabis sectors for Cowen, indicated US cannabis sales will reach US$80 billion by 2030.

Similarly, research firm Seaport Global issued its own cannabis report and initiated coverage in several stocks in the market.

“From a little over $12B in global value today, we see the market ultimately evolving to almost $630B in due time,” the firm indicated according to a report from New Cannabis Ventures.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

TransCanna (CSE: TCAN) (FSE: TH8) (“the Company”) is pleased to announce that plants are going into its first crop management site today – a greenhouse in Wesley, California.

The Company partnered with the 3rd generation cannabis farmers at 365 CannaFarms to consult on the construction of the state-of-the-art, computer-controlled greenhouse and to help manage the crop for the client, Central Valley Growers. The entire crop is comprised of premium genetic strains from Lyfted Farms, TransCanna‘s wholly-owned subsidiary.

Keep reading... Show less

Acquisition strengthens clinic portfolio for mental health treatment using psychedelic-assisted therapies

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced it has closed its acquisition of the Neurology Centre of Toronto (NCT), a leading Canadian provider of clinical neurologic care. The purchase agreement was previously announced on July 6, 2021 .

Keep reading... Show less

Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business’ first product line, RAF FIVE ™ through its dermatology subsidiary Ilera Derm LLC (“Zelira Dermatology”).

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

Hempsana Holdings Ltd. (the “ Company ” or “ Hempsana ”) is excited to announce that the Company has received approval from Health Canada to amend their cannabis licence to authorize the activity of sale of cannabis extracts, beverages, edibles, and topical products. The amended licence will allow Hempsana to supply and sell finished cannabis products directly to provincial distributors and other authorized Canadian retail supply channels.

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) ( CSE: HARV OTCQX: HRVSF ), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the opening of a new medical dispensary in Port St. Lucie, Florida .

Keep reading... Show less